title: [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
authors.forename: V G
authors.initials: VG
authors.lastname: Savchenko
authors.forename: E N
authors.initials: EN
authors.lastname: Parovichnikova
authors.forename: V G
authors.initials: VG
authors.lastname: Isaev
authors.forename: E P
authors.initials: EP
authors.lastname: Kulimova
authors.forename: R A
authors.initials: RA
authors.lastname: Kucher
authors.forename: A N
authors.initials: AN
authors.lastname: Sokolov
authors.forename: E N
authors.initials: EN
authors.lastname: Ustinova
authors.forename: E O
authors.initials: EO
authors.lastname: Gribanova
authors.forename: N D
authors.initials: ND
authors.lastname: Khoroshko
authors.forename: A V
authors.initials: AV
authors.lastname: Pivnik
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Tikhonova
authors.forename: G P
authors.initials: GP
authors.lastname: Sarkisian
authors.forename: E V
authors.initials: EV
authors.lastname: Domracheva
authors.forename: E R
authors.initials: ER
authors.lastname: Maslova
authors.forename: T S
authors.initials: TS
authors.lastname: Konstantinova
authors.forename: G B
authors.initials: GB
authors.lastname: Rekhtman
authors.forename: V A
authors.initials: VA
authors.lastname: Lapin
authors.forename: T I
authors.initials: TI
authors.lastname: Miliutina
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction; D012307:Risk Factors; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D008727:Methotrexate
vernacular_title: Lechenie ostrykh limfoblastnykh leĭkozov vzroslykh kak nereshennaia problema.